XDH-31401-58610
2 vaccinations
1 coded response
3 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 05-11
- ZIP prefix
- 457 / OH
- Registered
- 2022-06-29
- Relationship
- Child or adolescent in my care
- Guardian
- FYU-10313-70283
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-03-30
Dose 1 — Pfizer-BioNTech
-
2022-04-20
Dose 2 — Pfizer-BioNTech
-
2022-06-29
Registered in v-safe
-
2022-07-20
Survey response — 3 months, dose 2, dependentMedDRA: Cough, Discharge, Oropharyngeal pain, Respiratory tract congestion, Sleep disorder — Feeling: Fair · Be unable to work or attend schoolFree text: Cough Sore throat Congestion & drainage Disrupted sleepMedDRA releases: 2024-11 · check-in free text available
- 2022-10-19
- 2023-04-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-03-30 | Pfizer-BioNTech | No |
| 2 | 2022-04-20 | Pfizer-BioNTech | No |
Free text
Release 12 — 3 months, dose 2, dependent
Symptoms: Cough Sore throat Congestion & drainage Disrupted sleep
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Discharge | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Sleep disorder | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release